Skip to main content

Day: November 23, 2020

Brink’s to Present at the Bank of America 2020 Leveraged Finance Virtual Conference on November 30

RICHMOND, Va., Nov. 23, 2020 (GLOBE NEWSWIRE) — The Brink’s Company (NYSE:BCO), the global leader in total cash management, route-based secure logistics and payment solutions, today announced that Ron Domanico, executive vice president and chief financial officer, will participate in the Bank of America 2020 Leveraged Finance Virtual Conference on November 30, 2020.Brink’s management will be available to meet with investors throughout the day. Portfolio managers and analysts who wish to request a meeting should contact their Bank of America representative.The company’s presentation is scheduled for 4:30 PM ET. The webcast and presentation will be available in the Investor Relations Events section of the company’s website www.brinks.com. About The Brink’s CompanyThe Brink’s Company (NYSE:BCO) is the global leader in total cash management,...

Continue reading

PAE Completes Acquisition of Metis Solutions

FALLS CHURCH, Va., Nov. 23, 2020 (GLOBE NEWSWIRE) — PAE (NASDAQ: PAE, PAEWW), a global leader in delivering smart solutions to the U.S. government and its allies, today announced that it has completed its acquisition of Metis Solutions Corporation. The transaction expands and builds scale in PAE’s offerings for intelligence analysis, training and program support — high priority market areas of the U.S. government and allied nations.PAE President and CEO John Heller commented:“The acquisition of Metis strategically positions PAE with new and attractive customers and contract vehicles across the intelligence and defense communities. PAE, combined with Metis and the recently completed CENTRA Technology acquisition, significantly expands our capabilities across the intelligence and national security communities. These acquisitions deliver...

Continue reading

MeiraGTx to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

LONDON and NEW YORK, Nov. 23, 2020 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., president and chief executive officer, will participate in a fireside chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference. The virtual conference will be held from December 1-3, 2020.The pre-recorded fireside chat is currently available on the Investors page of the Company’s website at www.investors.meiragtx.com. A replay of the webcast will be available for approximately 90 days following the presentation.About MeiraGTxMeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs. MeiraGTx has...

Continue reading

Genetic Technologies Interview Aired on Bloomberg International on the RedChip Money Report

MELBOURNE, Australia, Nov. 23, 2020 (GLOBE NEWSWIRE) — Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce an interview with its interim-CEO, Dr. Jerzy Muchnicki aired on The RedChip Money Report television program. The RedChip Money Report airs in 100 million homes on Sundays at 6 p.m. local time in every country in Europe on Bloomberg International.In the exclusive interview, Dr. Muchnicki discusses the Company’s innovative disease risk assessment tests for COVID-19, cancer, and more.To view the interview segment, please visit: https://youtu.be/l3w_9HDvewM“The RedChip Money Report” delivers insightful commentary on small cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies.About...

Continue reading

KemPharm Provides Update on Development Pipeline

IND for KP879 Expected to be Filed Before Year-End 2020; New Prodrug Candidate Added to Pipeline, Targeting Rare CNS Disease, Idiopathic Hypersomnia (IH)CELEBRATION, Fla., Nov. 23, 2020 (GLOBE NEWSWIRE) — KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today provided an update to its prodrug development pipeline, including the expected filing of the Investigational New Drug (IND) application for KP879 with the U.S. Food and Drug Administration (FDA) prior to year-end 2020, and the introduction of a new prodrug candidate to its pipeline, KP1077. KemPharm is investigating KP1077 as a potential treatment for idiopathic hypersomnia (IH), which is an underserved, orphan disease indication.“Our primary focus during 2020 has been advancing KP415 into and...

Continue reading

Ayr Strategies Inc. Offers Short-Term Incentive for Cash Exercise of up to 3 Million Warrants

TORONTO, Nov. 23, 2020 (GLOBE NEWSWIRE) — Ayr Strategies (CSE: AYR.A, OTCQX: AYRSF, “Ayr” or “the Company”), a leading vertically integrated cannabis multi-state operator, announced today incentive exercise rights available on a short-term basis to the holders of the Company’s share purchase warrants (the “Warrants”) who exercise them for cash. The Warrants were issued pursuant to a Warrant Agency Agreement dated December 21, 2017, between the Company and Odyssey Trust Company, as warrant agent (the “Warrant Agent”), as amended (the “Warrant Agency Agreement”).Ayr will be offering a C$0.50 incentive for the cash-only exercise of up to 3 million Warrants, resulting in gross proceeds to the Company of approximately US$25 million if 3 million Warrants are exercised.“We are pleased to be able to offer our warrant holders this...

Continue reading

Griffin Announces Update on REIT Conversion, Dividend Plans, and Upcoming Rebranding

On track for conversion to a REIT effective January 1, 2021Accumulated earnings & profits to be distributed via dividend in the first quarter of 2021Change in fiscal year end from November 30thto December 31stGriffin to undergo a rebranding that will include a new company nameNEW YORK, Nov. 23, 2020 (GLOBE NEWSWIRE) — Griffin Industrial Realty, Inc. (Nasdaq: GRIF) (“Griffin” or the “Company”) today announced that its election to become a real estate investment trust (“REIT”) is on track and expected to become effective on January 1, 2021. On November 17, 2020, in connection with the anticipated election to become a REIT, the Company’s Board of Directors approved a change in the Company’s fiscal year end from November 30 to December 31, effective beginning with the Company’s next fiscal year, which will now begin on January 1,...

Continue reading

Update of the risk factors and other information available in the supplement related to the EMTN base prospectus

Paris, Amsterdam, November 23, 2020Press releaseUpdate of the risk factors and other information available in the supplement related to the EMTN base prospectusIn the context of its €20.0 Bn Euro Medium Term Note (EMTN) programme, Unibail-Rodamco-Westfield announces an update of the previously published risk factors of Unibail-Rodamco-Westfield SE and Unibail-Rodamco-Westfield N.V., and specifies hypotheses pertaining to the Group’s 2020 Adjusted Recurring Earnings per Share guidance and its 2021 Net Rental Income outlook in a supplement to the EMTN base prospectus dated August 5, 2020.Due to COVID-19, the Group may be exposed to a heightened risk, which is likely to have a material adverse effect on its operations, financial position and/or results, financial forecast/guidance and share price. The Group risk inventory presented has been...

Continue reading

Ballard Announces US$250 Million Bought Deal Offering of Common Shares

VANCOUVER, British Columbia, Nov. 23, 2020 (GLOBE NEWSWIRE) — Ballard Power Systems (“Ballard” or “the Company”) (NASDAQ: BLDP; TSX: BLDP) today announced that it has entered into an agreement with a syndicate of underwriters led by National Bank Financial Inc. and Raymond James Ltd. (the “Lead Underwriters” and together with the syndicate of underwriters, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 12,988,000 common shares of the Company (the “Common Shares”) at a price of US$19.25 per Common Share (the “Offering Price”) for gross proceeds of US$250,019,000 (the “Offering”). The Underwriters have also been granted an option (the “Over-Allotment Option”), exercisable in whole or in part and from time...

Continue reading

NANO DIMENSION CLOSES $100 MILLION REGISTERED DIRECT OFFERING

Sunrise, Florida, Nov. 23, 2020 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM), a leading Additively Manufactured Electronics (AME)/PE (Printed Electronics) provider, today announced it has closed the previously announced registered direct offering of 25,000,000 of the Company’s American Depositary Shares (“ADSs”) at a price of $4.00 per ADS. The gross proceeds of the offering were approximately $100 million, before deducting placement agent fees and other offering expenses. The Company intends to use the net proceeds for working capital and for other general corporate purposes, and pursuing strategic opportunities, including possible business combination transactions.ThinkEquity, a division of Fordham Financial Management, Inc., acted as sole placement agent for the offering.This offering was made pursuant to an effective...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.